India’s government is moving to fix a long-standing gap in pharma oversight by drafting basic rules for drug recalls. The move aims to bring clarity and consistency to when and how manufacturers withdraw faulty medicines, potentially reducing delays and protecting patients. After years of calls for stronger safeguards, regulators are finally focusing on recall procedures.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
